CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia

首次发布于 2021 年 12 月 23 日

Study Evaluating SC262 in Subjects With r/r Non-Hodgkin's Lymphoma (VIVID)

计划入组 6 人 · 首次发布于 2024 年 2 月 29 日

Anti-CD22 CAR-T Cell Therapy Targeting B Cell Malignancies

计划入组 20 人 · 首次发布于 2017 年 8 月 25 日

Allogeneic CD22-directed CAR T Cell Therapy(Sana Biotechnology)

JWTCR-001

Cell Therapy Ltd.

United Kingdom

Juventas Cell Therapy Ltd

China

Shanghai Cell Therapy Research Institute

China

Cargo Therapeutics Halts CD22 Cell Therapy Trial, Sparks Debate on Biotech Company Survival

Bicistronic CD19/CD22 CAR T-Cell Therapy Shows Durable Responses in Pediatric B-ALL

Canadian-Developed CAR T-Cell Therapy Targeting CD22 Heads to Clinical Trials